Tecnis Symfony IOL Approved by FDA for Cataract Patients

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

FDA Approves Tecnis Symfony IOL for Cataract Surgery Patients

Posted By Dr. Ari Weitzner On August 8, 2016 @ 12:15 pm In Cataract | Comments Disabled

On July 15, 2016, the FDA announced that it had approved the Tecnis Symfony intraocular lens (IOL) – the first IOL to provide cataract patients with an extended depth-of-focus, which helps improve their sharpness of vision at near, intermediate and far distances. In cataract surgery, the clouded natural lens is removed and replaced with an IOL.

As the FDA explained, traditional monofocal IOLs have been limited to improving distance vision. The Tecnis Symfony IOL improves visual acuity at close, intermediate and far ranges and, therefore, may reduce the need for patients to wear contact lenses or glasses after cataract surgery.

Click here ^[1] to read the FDA’s full announcement.

Click here to learn more about the Tecnis Symfony IOL ^[2].

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/007200-fda-approves-tecnis-symfony-iol-for-cataract-surgery-patients/

URLs in this post:

[1] Click here: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm511446.htm

[2] Click here to learn more about the Tecnis Symfony IOL: http://www.tecnisiol.com/eu/tecnis-symfony-iol.htm

Click here to print.